Sofinnova Investments, Inc. Homology Medicines, Inc. Transaction History

Sofinnova Investments, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$8.92 - $13.29 $2.12 Million - $3.16 Million	-238,015 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$9.94 - $16.59 $1.06 Million - $1.77 Million	-106,564 Reduced 30.93%	238,015 $2.55 Million
Q2 2020 Aug 13, 2020	BUY	$12.07 - $19.34 $1.37 Million - $2.2 Million	113,916 Added 49.39%	344,579 $5.23 Million
Q1 2020 May 13, 2020	BUY	$12.5 - $22.04 $2.08 Million - $3.66 Million	166,266 Added 258.19%	230,663 $3.58 Million
Q4 2019 Feb 14, 2020	SELL	$11.42 - $22.19 $935,298 - $1.82 Million	-81,900 Reduced 55.98%	64,397 $1.33 Million
Q3 2019 Nov 14, 2019	BUY	$14.74 - $22.28 $2.16 Million - $3.26 Million	146,297 New	146,297 $2.65 Million

66.2K

Ticker FIXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,402,000
Description
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Sofinnova Investments, Inc. with notifications on news.